1. Home
  2. Companies
  3. 22nd Century Group
  4. Financial Ratios
  5. P/S Ratio
22nd Century Group logo
22nd Century Group XXII
$ 1.98 -3.18%

Annual report 2025
added 03-26-2026

report update icon

22nd Century Group P/S Ratio 2011-2026 | XXII

Annual P/S Ratio 22nd Century Group

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
0.0308 0.000067 0.338 1.15 70.9 12.3 4.79 11 21.4 5.99 10 133 15.8 1.39 K 14.3

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.39 K 0.000067 113

P/S Ratio of other stocks in the Biotechnology industry

Issuer P/S Ratio Price % 24h Market Cap Country
AstraZeneca PLC AstraZeneca PLC
AZN
 		2.17 - - $ 96.9 B britainBritain
MorphoSys AG MorphoSys AG
MOR
 		1.75 - 2.43 % $ 254 M germanyGermany
Celldex Therapeutics Celldex Therapeutics
CLDX
 		1.32 K $ 34.55 2.04 % $ 2.29 B usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
 		131 $ 4.47 12.59 % $ 10.8 B australiaAustralia
Adverum Biotechnologies Adverum Biotechnologies
ADVM
 		76.4 - - $ 86.2 M usaUSA
I-Mab I-Mab
IMAB
 		94.1 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
 		5.53 - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
 		1.96 K - 2.54 % $ 160 B franceFrance
Aligos Therapeutics Aligos Therapeutics
ALGS
 		30.2 $ 6.68 -12.79 % $ 66 M usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
 		11 $ 309.66 -3.27 % $ 40.6 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
 		2.39 K - -1.52 % $ 24.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
 		137 - -18.52 % $ 27.3 M britainBritain
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
 		1.73 $ 22.88 4.91 % $ 1.07 B usaUSA
Applied Therapeutics Applied Therapeutics
APLT
 		54.1 - - $ 8.42 M usaUSA
BioNTech SE BioNTech SE
BNTX
 		35.7 $ 102.92 0.78 % $ 27.2 B germanyGermany
Aptinyx Aptinyx
APTX
 		204 - -39.0 % $ 4.57 M usaUSA
Aravive Aravive
ARAV
 		6.61 - -13.39 % $ 1.45 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
 		2.61 - - - russiaRussia
Advaxis Advaxis
ADXS
 		144 - -9.65 % $ 45.9 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
 		759 $ 3.04 -1.3 % $ 5 M israelIsrael
Aeterna Zentaris Aeterna Zentaris
AEZS
 		7.87 - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
 		0.099 - -10.17 % $ 12.2 K usaUSA
BioXcel Therapeutics BioXcel Therapeutics
BTAI
 		24 $ 1.15 7.48 % $ 14 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
 		489 - - $ 1.01 B usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
 		1.42 $ 1.41 4.07 % $ 363 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		11.2 - - $ 7.46 M israelIsrael
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
 		65.5 - - $ 26.5 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
 		10.5 $ 4.32 1.41 % $ 462 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
 		9.15 $ 24.53 1.41 % $ 3.12 B usaUSA
Burford Capital Limited Burford Capital Limited
BUR
 		6.35 $ 4.96 6.1 % $ 792 M britainBritain
AIkido Pharma AIkido Pharma
AIKI
 		0.935 - 1.93 % $ 17.4 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
 		1.85 - -4.8 % $ 255 M usaUSA
Cabaletta Bio Cabaletta Bio
CABA
 		50.3 M $ 3.44 -2.27 % $ 346 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
 		4.27 $ 1.6 -0.62 % $ 426 M britainBritain
BeiGene, Ltd. BeiGene, Ltd.
BGNE
 		66.4 - 0.49 % $ 251 B cayman-islandsCayman-islands
bluebird bio bluebird bio
BLUE
 		2.27 - - $ 546 M usaUSA
Citius Pharmaceuticals Citius Pharmaceuticals
CTXR
 		1.21 K $ 0.86 0.39 % $ 5.79 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
 		281 - - $ 867 M germanyGermany
Cidara Therapeutics Cidara Therapeutics
CDTX
 		116 - - $ 1.41 B usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
 		110 - - $ 3.45 B usaUSA